---
figid: PMC5220673__cvw218f7
figtitle: TSP1–CD47 signaling limits pulmonary cMyc to upregulate ET-1/ETA and promote
  PH
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
pmcid: PMC5220673
filename: cvw218f7.jpg
figlink: /pmc/articles/PMC5220673/figure/cvw218-F7/
number: F7
caption: TSP1–CD47 signaling limits pulmonary cMyc to upregulate ET-1/ETA and promote
  PH. Hypoxia-mediated induction of TSP1 in the pulmonary vasculature activates endothelial
  CD47 to suppress cMyc allowing upregulation of ET-1/ETA. ET-1 then targets the pulmonary
  arterial vascular smooth muscle cell (VSMC) compartment to promote vascular remodeling
  and cell hypertrophy, decreased vasodilation and increased vasoconstriction. Conversely,
  treatment with a CD47 antibody, that blocks TSP1 activation of CD47, limits ET-1-mediated
  VSMC hypertrophy and improves PA sensitivity to NO pathway activators.
papertitle: TSP1–CD47 signaling is upregulated in clinical pulmonary hypertension
  and contributes to pulmonary arterial vasculopathy and dysfunction.
reftext: Natasha M. Rogers, et al. Cardiovasc Res. 2017 Jan;113(1):15-29.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9620608
figid_alias: PMC5220673__F7
figtype: Figure
redirect_from: /figures/PMC5220673__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5220673__cvw218f7.html
  '@type': Dataset
  description: TSP1–CD47 signaling limits pulmonary cMyc to upregulate ET-1/ETA and
    promote PH. Hypoxia-mediated induction of TSP1 in the pulmonary vasculature activates
    endothelial CD47 to suppress cMyc allowing upregulation of ET-1/ETA. ET-1 then
    targets the pulmonary arterial vascular smooth muscle cell (VSMC) compartment
    to promote vascular remodeling and cell hypertrophy, decreased vasodilation and
    increased vasoconstriction. Conversely, treatment with a CD47 antibody, that blocks
    TSP1 activation of CD47, limits ET-1-mediated VSMC hypertrophy and improves PA
    sensitivity to NO pathway activators.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tsp1
  - Gzma
  - Thbs1
  - Cd47
  - Edn1
  - Ednra
  - Spp1
  - THBS1
  - CRISP2
  - PRSS55
  - CD47
  - MYC
  - EDN1
  - EDNRA
---
